Publications by authors named "Hanan Alharthy"

Claim this Profile
L
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.
Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Hanan Alharthy

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia presenting as an atraumatic splenic rupture in the setting of coronavirus disease 2019 infection.
Hanan Alharthy, Jaclyn Clark, Rima Koka, Ali Aldahmashi, Maria R Baer

EJHaem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.
Jennifer Strong, Albert E Zhou, Fahad Alkaabba, Danielle Soldin, Joanne Moon, Hanan Alharthy

Case Rep Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of -ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study.
Elizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, Kathryn A F Kline, Danielle Sewell

Biology (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study.
Elizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, Kathryn A F Kline, Danielle Sewell

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study.
Moaath K Mustafa Ali, Elizabeth M Corley, Hanan Alharthy, Kathryn A F Kline, Jennie Y Law

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Hanan Alharthy

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women.
Naela Agha, Bader Alshamsan, Sharifa Al-Farsi, Heba Aly Ateya, Fahad A Almugbel, Hanan Alharthy

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis